Study demonstrates that peptide shuttles reduce neurotoxicity in Alzheimer's, suggesting a novel therapeutic approach.
Alzheimer’s disease (AD) remains the most prevalent neurodegenerative disease characterized by intracellular neurofibrillary tangles of Tau protein and extracellular senile plaques build on Amyloid-β (Aβ) peptides. The latter result from...
No takes yet. Share an insight, caveat, or question.
Okafor et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: